{"mainPropery":{"diseaseId":3582,"diseaseName":"Methylmalonic acidemia with homocystinuria type cblD","hasGardWebPage":false,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3582/methylmalonic-acidemia-with-homocystinuria-type-cbld","synonyms":["HOMOCYSTINURIA, cblD TYPE, VARIANT 1, INCLUDED","METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2, INCLUDED","METHYLMALONIC ACIDURIA, cblH TYPE, FORMERLY","METHYLMALONIC ACIDEMIA, cblH TYPE, FORMERLY","CblD defect","Cobalamin D defect","Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblD","Methylmalonic aciduria with homocystinuria, type cblD","METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblD TYPE","Mehtylmalonic acidemia with homocystinuria cbI d","Methylmalonic acidemia with homocystinuria, type cblD"],"synonyms-with-source":[{"name":"HOMOCYSTINURIA, cblD TYPE, VARIANT 1, INCLUDED","source":"OMIM"},{"name":"METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2, INCLUDED","source":"OMIM"},{"name":"METHYLMALONIC ACIDURIA, cblH TYPE, FORMERLY","source":"OMIM"},{"name":"METHYLMALONIC ACIDEMIA, cblH TYPE, FORMERLY","source":"OMIM"},{"name":"CblD defect","source":"Orphanet"},{"name":"Cobalamin D defect","source":"Orphanet"},{"name":"Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblD","source":"Orphanet"},{"name":"Methylmalonic aciduria with homocystinuria, type cblD","source":"Orphanet"},{"name":"METHYLMALONIC ACIDEMIA AND HOMOCYSTINURIA, cblD TYPE","source":"OMIM"},{"name":"Mehtylmalonic acidemia with homocystinuria cbI d","source":""},{"name":"Methylmalonic acidemia with homocystinuria, type cblD","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"277410"},{"identifierType":"ORPHANET","identifierId":"79283"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":221,"resourceName":"Organic Acidemia Association","abbreviation":"","address1":"9040 Duluth Street","address2":"","address3":"","address4":"","address5":"","city":"Golden Valley","state":"MN","zip":"55427","country":"United States","phone":"763-559-1797","tty":"","tollFree":"","fax":"866-539-4060","email":"mkstagni@gmail.com","url":"http://www.oaanews.org/","freeText":""},{"resourceID":3595,"resourceName":"HCU Network America","abbreviation":"","address1":"623 Creek Lane","address2":"","address3":"","address4":"","address5":"","city":"Flourtown","state":"PA","zip":"19031","country":"United States","phone":"630-360-2087","tty":"","tollFree":"","fax":"","email":"info@hcunetworkamerica.org","url":"http://hcunetworkamerica.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/277410' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=277410' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Methylmalonic acidemia with homocystinuria type cblD. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/methylmalonic-acidemia-with-homocystinuria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Methylmalonic acidemia with homocystinuria type cblD. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/methylmalonic-acidemia-with-homocystinuria' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1321,"resourceId":1982,"resourceName":"National Newborn Screening and Global Resource Center","descriptionText":"<a href='https://www.newbornscreening.info/iva-isovaleric-acidemia/' target='_blank'>National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/427/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79283' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1535,"resourceId":2166,"resourceName":"ACTion (ACT) sheet","descriptionText":"An  <a href='https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf' target='_blank'>ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=cbl' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1546,"resourceId":2174,"resourceName":"Algorithm","descriptionText":"An <a href='https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf' target='_blank'>Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:277410' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9659,"questionText":"What is methylmalonic acidemia with homocystinuria, type cblD?","answerText":"<strong>Methylmalonic acidemia with homocystinuria, type cblD</strong> is an inherited condition in which the body is unable to <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002257.htm\" tabindex=\"-1\" target=\"_blank\">metabolize</a> certain proteins and fats properly. Signs and symptoms generally develop in the first few months of life and may include <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000991.htm\" tabindex=\"-1\" target=\"_blank\">failure to thrive</a>, lethargy, vomiting, dehydration, <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003298.htm\" tabindex=\"-1\" target=\"_blank\">hypotonia</a>, developmental delay, seizures, ataxia (problems with muscle control), feeding difficulties, and an enlarged liver (hepatomegaly). Intellectual disability is a long-term consequence. Methylmalonic acidemia with homocystinuria, type cblD is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" tabindex=\"-1\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/MMADHC\" tabindex=\"-1\" target=\"_blank\">MMADHC</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" tabindex=\"-1\" target=\"_blank\">autosomal recessive</a> manner. There is no cure for the condition. Treatments are focused on alleviating some of the associated symptoms and may include various medications and/or supplements.[4437][9017]","dateModified":"2015-11-09T20:32:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":3579,"relatedDiseaseName":"Methylmalonic acidemia with homocystinuria","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13430,"phenoTypeName":"Anorexia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6005,"phenoTypeName":"Behavioral abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13085,"phenoTypeName":"Megaloblastic bone marrow","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8266,"phenoTypeName":"Pallor","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13743,"phenoTypeName":"Cerebral cortical atrophy","percentRanges":"-"},{"phenoTypeId":14585,"phenoTypeName":"Decreased adenosylcobalamin","percentRanges":"-"},{"phenoTypeId":13621,"phenoTypeName":"Decreased methionine synthase activity","percentRanges":"-"},{"phenoTypeId":14523,"phenoTypeName":"Decreased methylcobalamin","percentRanges":"-"},{"phenoTypeId":14514,"phenoTypeName":"Decreased methylmalonyl-CoA mutase activity","percentRanges":"-"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":13835,"phenoTypeName":"Homocystinuria","percentRanges":"-"},{"phenoTypeId":13836,"phenoTypeName":"Hyperhomocystinemia","percentRanges":"-"},{"phenoTypeId":5248,"phenoTypeName":"Hypomethioninemia","percentRanges":"-"},{"phenoTypeId":9555,"phenoTypeName":"Increased mean corpuscular volume","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":15527,"phenoTypeName":"Megaloblastic anemia","percentRanges":"-"},{"phenoTypeId":4320,"phenoTypeName":"Methylmalonic acidemia","percentRanges":"-"},{"phenoTypeId":2725,"phenoTypeName":"Methylmalonic aciduria","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","percentRanges":"-"},{"phenoTypeId":14288,"phenoTypeName":"Spastic ataxia","percentRanges":"-"}],"medicalProducts":[{"productId":286,"genericName":"Betaine","tradeName":"Cystadane","tradeLink":"http://www.cystadane.com/","manufacturer":"","sponsor":"Orphan Europe SARL","indication":"Treatment of homocystinuria to decrease elevated homocysteine blood levels.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/107-43-7","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a608012.html"}],"EncodedName":"Methylmalonic_acidemia_with_homocystinuria_type_cblD"}